We are live on
!
Find out more
Design Therapeutics
DSGN
DSGN
125 hedge funds and large institutions have $404M invested in Design Therapeutics in 2026 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 55 increasing their positions, 29 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
90% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 29
69% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 13
13% more capital invested
Capital invested by funds: $358M → $404M (+$46.3M)
7% more funds holding
Funds holding: 117 → 125 (+8)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5.37% less ownership
Funds ownership: 66.97% → 61.59% (-5.4%)
Holders
125
Holders Change
+8
Holders Change %
+6.84%
% of All Funds
1.54%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
22
Increased
55
Reduced
29
Closed
13
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$4.59M
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$15.3M |
| 2 |
TECP
Trails Edge Capital Partners
Atlanta,
Georgia
|
+$8.62M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$5.72M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$3.57M |
| 5 |
Goldman Sachs
New York
|
+$2.37M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$26.8M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
-$5.57M |
| 3 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$4.89M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.31M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$1.66M |
